Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 11/20 | 0.32 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.32 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.30 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.30 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5964919 | 0.98 | TSHR (0.38) | TSHRTHRBFDPSGGPS1CES2 | |
| SCHEMBL28214778 | 0.98 | TSHR (0.38) | TSHRTHRBFDPSGGPS1CES2 | |
| SCHEMBL20609969 | 0.92 | LMNA (0.30) | TSHR | |
| SCHEMBL8737387 | 0.91 | OPRM1 (0.31) | OPRM1TSHRTHRBFDPSGGPS1 | |
| SCHEMBL598457 | 0.81 | MMP8 (0.32) | — | |
| SCHEMBL17607653 | 0.81 | CES2 (0.32) | OPRM1TSHRTHRBFDPSGGPS1 | |
| SCHEMBL1657359 | 0.81 | FDPS (0.34) | FDPSGGPS1 | |
| SCHEMBL25408915 | 0.79 | CES2 (0.35) | TSHRTHRBFDPSGGPS1CES2 | |
| SCHEMBL14154955 | 0.79 | OPRM1 (0.44) | OPRM1TSHRTHRBFDPSGGPS1 | |
| SCHEMBL8896811 | 0.79 | GGPS1 (0.38) | FDPSGGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3283175-B1 | SOLID CONDITIONING COMPOSITION | PROCTER & GAMBLE (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-3283172-B1 | SOLID CONDITIONING COMPOSITION | PROCTER & GAMBLE (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-3283174-B1 | METHOD EMPLOYING, AND USE OF, A SOLID CONDITIONING COMPOSITION | PROCTER & GAMBLE (US) | 2026-05-06 | — | — | EP | disclosed |
| US-12496565-B2 | Microcapsule and hair care composition | CONOPCO, INC. (US) | 2025-12-16 | — | — | US | disclosed |
| US-12491147-B2 | Personal care compositions comprising a metal piroctone complex | CONOPCO, INC. (US) | 2025-12-09 | — | — | US | disclosed |
| EP-4197598-B1 | ACTIVE AGENT-CONTAINING ARTICLES THAT EXHIBIT CONSUMER ACCEPTABLE ARTICLE IN-USE PROPERTIES | PROCTER & GAMBLE (US) | 2025-10-22 | — | — | EP | disclosed |
| EP-4630525-A1 | LAUNDRY TREATMENT COMPOSITION INCLUDING A POLYALKYLENECARBONATE COMPOUND | The Procter & Gamble Company (US) | 2025-10-15 | — | — | EP | disclosed |
| EP-3915643-B1 | ACTIVE AGENT-CONTAINING ARTICLES THAT EXHIBIT CONSUMER ACCEPTABLE ARTICLE IN-USE PROPERTIES | PROCTER & GAMBLE (US) | 2025-08-20 | — | — | EP | disclosed |
| US-12285515-B2 | Microcapsule and hair care composition | CONOPCO, INC. (US) | 2025-04-29 | — | — | US | disclosed |
| US-12268765-B2 | Personal care compositions substantially free of sulfated surfactants and containing a gel network | THE PROCTER & GAMBLE COMPANY (US) | 2025-04-08 | — | — | US | disclosed |
| EP-0461072-B1 | Process for the preparation of polyurethanes using specific stabilizer systems | CIBA GEIGY AG (CH) | 1998-07-29 | — | — | EP | disclosed |
| EP-0706366-B1 | CONDITIONING SHAMPOOS CONTAINING POLYVALENT METAL CATIONS | PROCTER & GAMBLE (US) | 1998-07-29 | — | — | EP | disclosed |
| WO-1997035546-A1 | CONDITIONING SHAMPOO COMPOSITIONS CONTAINING SELECT HAIR CONDITIONING AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1997-10-02 | — | — | WO | disclosed |
| EP-0644749-B1 | COOLANT COMPOSITIONS WITH REDUCED STINGING | PROCTER & GAMBLE (US) | 1997-08-20 | — | — | EP | disclosed |
| EP-0610407-B1 | SHAMPOO COMPOSITIONS WITH SILICONE, CATIONIC POLYMER, AND OILY LIQUID CONDITIONING AGENTS | PROCTER & GAMBLE (US) | 1996-08-28 | — | — | EP | disclosed |
| EP-0312270-B1 | Antiperspirant creams and manufacture thereof | PROCTER & GAMBLE (US) | 1994-02-02 | — | — | EP | disclosed |
| US-5077321-A | Using two structurally different stabilizers | CIBA-GEIGY CORPORATION (US) | 1991-12-31 | — | — | US | disclosed |
| EP-0461072-A2 | Process for the preparation of polyurethanes using specific stabilizer systems | CIBA-GEIGY AG (CH) | 1991-12-11 | — | — | EP | disclosed |
| EP-0437416-A2 | Compositions containing a 2,2',2\"-nitrilotriethanol-cyclometallate | CIBA-GEIGY AG (CH) | 1991-07-17 | — | — | EP | disclosed |
| EP-0428973-A1 | Mixtures of stabilisers for elastomers | CIBA-GEIGY AG (CH) | 1991-05-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12268765-B2 | Personal care compositions substantially free of sulfated surfactants and containing a gel network | DSG1, DEGS1, POLN | OPRM1 3461/4885TSHR 2229/4885THRB 3146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.